New Benchmarks on Protocol Amendment Experience in Oncology Clinical Trials
Description
CONCLUSIONS: Efforts to prevent avoidable protocol amendments in the industry have not been effective in oncology, where increasingly complex designs are reflected in difficult to predict cycle times, barriers to recruitment and retention and an
